儿童及青少年甲状腺癌幸存者的生存照护、生活质量与向成人医疗过渡
本文阐述儿童及青少年甲状腺癌幸存者长期生存照护的重要性,指出多数幸存者随年龄增长面临更多医学和心理社会共病及早亡风险,几乎所有患者需终身甲状腺激素替代治疗,应实施生存照护与过渡照护计划并定期评估患者及家庭需求和生活质量。
要点
- 儿童甲状腺癌幸存者部分有显著治疗并发症或远期效应,部分无长期医学远期效应,但几乎所有患者需终身甲状腺激素替代治疗。
- 多数儿童癌症幸存者随年龄增长医学和心理社会共病增加,早亡风险更高,且因癌症诊断而异。
- 应为年轻甲状腺癌幸存者实施生存照护和过渡照护计划(SCP/TCP),并定期评估患者及家庭需求和生活质量。
核心结论
- 应为年轻甲状腺癌幸存者实施生存照护和过渡照护,包括生存照护和/或过渡照护计划(SCP/TCP),并定期评估患者及家庭的需求和生活质量。
主要发现
- 多数儿童癌症幸存者随年龄增长医学和心理社会共病增加,早亡风险更高,且因癌症诊断而异。
- 儿童甲状腺癌幸存者中部分有显著治疗并发症和/或远期效应,部分无长期医学远期效应,但几乎所有患者需终身甲状腺激素替代治疗。
临床怎么用
- 应为年轻甲状腺癌幸存者实施生存照护和过渡照护,包括生存照护和/或过渡照护计划(SCP/TCP)。
- 应定期评估甲状腺癌幸存者患者及家庭的需求和生活质量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The importance of long-term survivorship care to reduce survivor and family anxiety and burden, decrease emergency visits and health care costs, improve knowledge, as well as implement timely surveillance is widely accepted. Most childhood cancer survivors suffer from an increased number of medical and psychosocial comorbidities as they age and are at a higher risk for early mortality, which differs by cancer diagnosis. Childhood thyroid cancer survivors fall within this spectrum. Some have significant complications and/or late effects from treatment, whereas others have no long-term medical late effects, but almost all will require life-long thyroid hormone replacement therapy. Therefore, providing survivorship and transitional care, including a survivorship and/or transitional care plan (SCP/TCP), as well as periodically assessing the needs and quality of life for the patient and their family, should be implemented for our young thyroid cancer survivors.
引用
- Goldfarb M, Franco AT. Survivorship, Quality of Life, and Transition to Adult Care for Pediatric and Adolescent Thyroid Cancer Survivors. Thyroid. 2022. PMID: 36193568. doi:10.1089/thy.2022.0407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。